CHARLES TOWN, W.Va., June 2 /PRNewswire-USNewswire/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum today announced a record breaking sales day on April 22nd, when they sold over $26,500 in products.
"Our business is growing so fast that we can hardly keep up with orders," says Brian Sheldon, General Production Manager. "We are nearly finished with our building expansion project which will result in doubling our manufacturing space and 8 additional offices for marketing staff."
ReBuilder Medical Technologies, Inc., RBRM, (established in 2001) is the brainchild of the prolific inventor David B. Phillips, Ph.D. who has a successful history of inventing innovative medical devices, ranging from Breast cancer detection to its newest product, launched last week, the Acne-Pen(TM), a $99 electronic device that painlessly eliminates pimples overnight without messy creams.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
|SOURCE ReBuilder Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved